Advances in SNEDDS Tablets: Marketed Formulations and Emerging Technologies for Precision Drug Delivery

Self-nanoemulsifying drug delivery systems (SNEDDS) are transforming the oral delivery of poorly soluble drugs by improving their solubility and bioavailability. Although SNEDDS formulations available in the market have demonstrated favourable results, technological advancements are paving the way for a new era in drug delivery. This review assesses the current state of SNEDDS tablets in the pharmaceutical industry, emphasizing notable formulations and their performance outcomes. It also examines the future potential of SNEDDS and its solid forms and uses High Pressure Homogenisation Technique for conversion, investigating innovative methods like 3D printing, AI-driven formulation optimization, and precision drug delivery. These cutting-edge strategies could personalize treatments, enhance patient adherence, and improve therapeutic results. Additionally, this article discusses the challenges and opportunities that arise from incorporating these technologies into the development of SNEDDS.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-22
DOI
https://doi.org/10.5281/zenodo.15716607
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advances in SNEDDS Tablets: Marketed Formulations and Emerging Technologies for Precision Drug Delivery

Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

Advances in SNEDDS Tablets: Marketed Formulations and Emerging Technologies for Precision Drug Delivery

article en

Abstract

Self-nanoemulsifying drug delivery systems (SNEDDS) are transforming the oral delivery of poorly soluble drugs by improving their solubility and bioavailability. Although SNEDDS formulations available in the market have demonstrated favourable results, technological advancements are paving the way for a new era in drug delivery. This review assesses the current state of SNEDDS tablets in the pharmaceutical industry, emphasizing notable formulations and their performance outcomes. It also examines the future potential of SNEDDS and its solid forms and uses High Pressure Homogenisation Technique for conversion, investigating innovative methods like 3D printing, AI-driven formulation optimization, and precision drug delivery. These cutting-edge strategies could personalize treatments, enhance patient adherence, and improve therapeutic results. Additionally, this article discusses the challenges and opportunities that arise from incorporating these technologies into the development of SNEDDS.

Zenodo (CERN European Organization for Nuclear Research)
Industry, innovation and infrastructure
Openalex Percentile: Top 64%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Advances in SNEDDS Tablets: Marketed Formulations and Emerging Technologies for Precision Drug Delivery · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS